Zai Lab (NASDAQ:ZLAB) reported on Wednesday second quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Zai Lab announced earnings per share of $-1.03 on revenue of $9.58M. Analysts polled by anticipated EPS of $-1.03 on revenue of $9.58M. That with comparison to EPS of $-0.67 on revenue of $36K in the same period a year before. Zai Lab had reported EPS of $-0.6 on revenue of $-1.64M in the previous quarter. Analysts are expecting EPS of $-1.03 and revenue of $9.58M in the upcoming quarter.
Zai Lab shares are up 75.86% from the beginning of the year , still down 4.25% from its 52 week high of $76.39 set on May 19. They are outperforming the Nasdaq which is up 7.12% year to date.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings beat by Bristol-Myers Squibb on May 7, who reported EPS of $1.72 on revenue of $10.78B, compared to forecasts EPS of $1.49 on revenue of $10.03B.
Medtronic had missed expectations on May 21 with fourth quarter EPS of $0.58 on revenue of $6B, compared to forecast for EPS of $0.95 on revenue of $6.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
